GUANGZHOU, China--(BUSINESS WIRE)--The ChinaBio® Investor Forum – Guangzhou chose two early stage life science companies as the “Most Promising” of the 14 presenting companies at the recently held conference. MingSight Pharmaceuticals was selected in the pharmaceutical category, and Cyagen Biosciences was named in the tools and services group. The ChinaBio event, which was held December 21, brought together more than 330 attendees, including over 50 international VCs and investors.
